3 Psychedelic Sector Leaders That Investors Need To Be Aware OfPsyched Wellness Announces New OTCQB Ticker: PSYCF2 Psychedelic Bellwethers That Are Gearing Up To Go Public In 2021Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use DisorderMindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial ExperiencePure Extracts (CSE:PULL) – A Leading Canadian Mushroom Extraction PlatformPsyched Wellness’ Mycological Research Continues To Take Serious Strides ForwardMindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic TherapeuticsPure Extracts Continues To Build Out Its Comprehensive Mushroom Extraction PlatformMYND Life Sciences Inc. Closes $2.4 Million Private Placement and Provides Update on Planned ListingTryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory BoardCYBIN Provides Update on Patent Filings & Development of Therapeutics ProgramNuminus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic ProductsPsyched Wellness Commences Antioxidant and Anti-Inflammatory Study on MuscimolMindset Generates Promising In Vitro Results from Third Patent Family of Novel Psychedelic Compounds Suggesting Range of3 Drug Development Companies Leveraging Psychedelic Compounds In Clinical TrialsEntheon Biomedical Announces Investment and Business Arrangement with Heading Health LLCPsyched Wellness Has Commenced Research on Muscimol for Various AilmentsAion Therapeutic Announces Closing of Non-Brokered Private Placement
Back

The Psychedelic Sector Is Getting A Major Momentum Boost Post U.S. Election

Nov 4, 2020 • 8:33 AM EST
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

The US election proved to be a catalyst for the psychedelic therapy industry after two major ballot initiatives were passed in the District of Columbia and in Oregon.

According to the Associated Press, D.C. voters passed legislation that would make the possession and use of certain psychedelic plants the lowest level on the enforcement priority scale for police.

The next steps for the legislation require it to be sent to the DC Council for review. Since the legislation includes federal land, after the bill is sent to the council it would have to be reviewed by congress.

Based off the way the District of Columbia viewed cannabis, we expect the process for psychedelic plants to be complex. We believe that the passing of the legislation represents an important development for the industry and will monitor how the legislation progresses from here.

The bill that passed in Oregon was for the legalization of psilocybin mushrooms that are for medical purposes. The state was one of the first to get on the psychedelic therapy bandwagon and we are favorable on how the legislation was received by voters.

If the legislation in D.C. passes, a range of psychedelic plants and fungi could be decriminalized, and this would prove to be a catalyst for the industry. By decriminalizing the possession and use of certain psychedelic plants, the district would be setting a precedent for other states to follow and will monitor how the industry continues to advance.

The passing of the legislation reminds us of the birth of the cannabis industry. It took decades for the legal cannabis industry to get to where it is today in the US and we do not expect the process to be any different for psychedelic plants. Over the next year, we expect to see additional legislation on the possession and use of certain psychedelic plants to become a trend in other states and are bullish on the way the industry is trending.

If you are interested in learning more about the landscape of the psychedelic therapy market, please send an email to support@mushrooomstocks.com with the subject “psychedelic therapy companies” to be added to our distribution list.

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link